BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22050085)

  • 1. Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.
    Jensen PC; Thiele S; Steen A; Elder A; Kolbeck R; Ghosh S; Frimurer TM; Rosenkilde MM
    Br J Pharmacol; 2012 May; 166(1):258-75. PubMed ID: 22050085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding.
    Barington L; Rummel PC; Lückmann M; Pihl H; Larsen O; Daugvilaite V; Johnsen AH; Frimurer TM; Karlshøj S; Rosenkilde MM
    J Biol Chem; 2016 Jul; 291(31):16208-20. PubMed ID: 27226537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8.
    Jensen PC; Nygaard R; Thiele S; Elder A; Zhu G; Kolbeck R; Ghosh S; Schwartz TW; Rosenkilde MM
    Mol Pharmacol; 2007 Aug; 72(2):327-40. PubMed ID: 17652183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular disulfide bridges serve different purposes in two homologous chemokine receptors, CCR1 and CCR5.
    Rummel PC; Thiele S; Hansen LS; Petersen TP; Sparre-Ulrich AH; Ulven T; Rosenkilde MM
    Mol Pharmacol; 2013 Sep; 84(3):335-45. PubMed ID: 23765404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.
    Rummel PC; Arfelt KN; Baumann L; Jenkins TJ; Thiele S; Lüttichau HR; Johnsen A; Pease J; Ghosh S; Kolbeck R; Rosenkilde MM
    Br J Pharmacol; 2012 Nov; 167(6):1206-17. PubMed ID: 22708643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships and identification of optmized CC-chemokine receptor CCR1, 5, and 8 metal-ion chelators.
    Chalikiopoulos A; Thiele S; Malmgaard-Clausen M; Rydberg P; Isberg V; Ulven T; Frimurer TM; Rosenkilde MM; Gloriam DE
    J Chem Inf Model; 2013 Nov; 53(11):2863-73. PubMed ID: 24083637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
    Thiele S; Malmgaard-Clausen M; Engel-Andreasen J; Steen A; Rummel PC; Nielsen MC; Gloriam DE; Frimurer TM; Ulven T; Rosenkilde MM
    J Med Chem; 2012 Sep; 55(18):8164-77. PubMed ID: 22957890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 8. Activation mechanisms of chemokine receptors.
    Jensen PC; Rosenkilde MM
    Methods Enzymol; 2009; 461():171-90. PubMed ID: 19480919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist.
    de Mendonça FL; da Fonseca PC; Phillips RM; Saldanha JW; Williams TJ; Pease JE
    J Biol Chem; 2005 Feb; 280(6):4808-16. PubMed ID: 15548526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological characterization of ligands targeting the human CC chemokine receptor 8 (CCR8) reveals the biased signaling properties of small molecule agonists.
    Liu L; Doijen J; D'huys T; Verhaegen Y; Dehaen W; De Jonghe S; Schols D; Van Loy T
    Biochem Pharmacol; 2021 Jun; 188():114565. PubMed ID: 33872569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multistep continuous-flow synthesis in medicinal chemistry: discovery and preliminary structure-activity relationships of CCR8 ligands.
    Petersen TP; Mirsharghi S; Rummel PC; Thiele S; Rosenkilde MM; Ritzén A; Ulven T
    Chemistry; 2013 Jul; 19(28):9343-50. PubMed ID: 23716302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GluVII:06--a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors.
    Rosenkilde MM; Schwartz TW
    Curr Top Med Chem; 2006; 6(13):1319-33. PubMed ID: 16918451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive versus negative modulation of different endogenous chemokines for CC-chemokine receptor 1 by small molecule agonists through allosteric versus orthosteric binding.
    Jensen PC; Thiele S; Ulven T; Schwartz TW; Rosenkilde MM
    J Biol Chem; 2008 Aug; 283(34):23121-8. PubMed ID: 18559339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring a model of a chemokine receptor/ligand complex in an explicit membrane environment by molecular dynamics simulation: the human CCR1 receptor.
    Shahlaei M; Madadkar-Sobhani A; Fassihi A; Saghaie L
    J Chem Inf Model; 2011 Oct; 51(10):2717-30. PubMed ID: 21910472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8.
    Jiang S; Lin X; Wu L; Wang L; Wu Y; Xu Z; Xu F
    Sci Adv; 2024 Feb; 10(5):eadj7500. PubMed ID: 38306437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5).
    Karlshøj S; Amarandi RM; Larsen O; Daugvilaite V; Steen A; Brvar M; Pui A; Frimurer TM; Ulven T; Rosenkilde MM
    J Biol Chem; 2016 Dec; 291(52):26860-26874. PubMed ID: 27834679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation.
    Vaidehi N; Schlyer S; Trabanino RJ; Floriano WB; Abrol R; Sharma S; Kochanny M; Koovakat S; Dunning L; Liang M; Fox JM; de Mendonça FL; Pease JE; Goddard WA; Horuk R
    J Biol Chem; 2006 Sep; 281(37):27613-20. PubMed ID: 16837468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
    Fox JM; Najarro P; Smith GL; Struyf S; Proost P; Pease JE
    J Biol Chem; 2006 Dec; 281(48):36652-61. PubMed ID: 17023422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.
    Onuffer J; McCarrick MA; Dunning L; Liang M; Rosser M; Wei GP; Ng H; Horuk R
    J Immunol; 2003 Feb; 170(4):1910-6. PubMed ID: 12574358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism.
    Holst B; Mokrosinski J; Lang M; Brandt E; Nygaard R; Frimurer TM; Beck-Sickinger AG; Schwartz TW
    J Biol Chem; 2007 May; 282(21):15799-811. PubMed ID: 17371869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.